| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Laboratory of Pathology,*
National Cancer
Institute; the Surgery Branch,
National Cancer
Institute; the Department of Radiology,
Warren G. Magnuson Clinical Center; and the Urologic Oncology
Branch,§
National Cancer Institute, National
Institutes of Health, Bethesda, Maryland
Although pancreatic neuroendocrine tumors (NETs) in von Hippel-Lindau (VHL) disease have been reported, their pathological features have not been characterized. In addition, it is unknown whether alterations of the VHL gene are responsible for pancreatic NET development. To evaluate NETs in VHL patients, we performed histopathological analysis of 30 pancreatic tumors in 14 patients. In addition, DNA from NETs and normal pancreatic tissue from 6 patients with documented germ-line VHL gene mutations was studied for allelic deletions of the second copy of the VHL gene by fluorescence in situ hybridization and polymerase chain reaction-based single-strand conformational polymorphism analysis. Morphologically, the tumors were characterized by solid, trabecular, and/or glandular architecture and prominent stromal collagen bands. Sixty percent of the tumors revealed at least focally clear-cell cytology. All tumors were positive for panendocrine immunohistochemistry markers (chromogranin A and/or synaptophysin); 35% of NETs demonstrated focal positivity for pancreatic polypeptide, somatostatin, insulin, and/or glucagon; and no immunostaining for pancreatic and gastrointestinal hormones was observed in 65% of tumors. Dense core neurosecretory granules were evident by electron microscopic examination, and the clear cells additionally revealed abundant intracytoplasmic lipid. All NETs that were subjected to genetic analysis showed allelic loss of the second copy of the VHL gene. We conclude that multiple, nonfunctional pancreatic NETs occur in VHL patients. Stromal collagen bands and clear-cell morphology are important histological features of VHL-associated NETs. The presence of allelic deletions of the VHL gene in pancreatic NETs provides direct molecular evidence for a role of the gene in their tumorigenesis and establishes NET as an independent tumor type of VHL disease.
This article has been cited by other articles:
 |
|
 |
|
  A M Schmitt, S Schmid, T Rudolph, M Anlauf, C Prinz, G Kloppel, H Moch, P U Heitz, P Komminoth, and A Perren VHL inactivation is an important pathway for the development of malignant sporadic pancreatic endocrine tumors Endocr. Relat. Cancer, December 1, 2009; 16(4): 1219 - 1227. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Ehehalt, H. D. Saeger, C. M. Schmidt, and R. Grutzmann Neuroendocrine Tumors of the Pancreas Oncologist, May 1, 2009; 14(5): 456 - 467. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Puri, D. A. Cano, and M. Hebrok A Role for von Hippel-Lindau Protein in Pancreatic {beta}-Cell Function Diabetes, February 1, 2009; 58(2): 433 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Henopp, M. Anlauf, A. Schmitt, R. Schlenger, A. Zalatnai, A. Couvelard, P. Ruszniewski, K.-P. Schaps, Y. M. H. Jonkers, E.-J. M. Speel, et al. Glucagon Cell Adenomatosis: A Newly Recognized Disease of the Endocrine Pancreas J. Clin. Endocrinol. Metab., January 1, 2009; 94(1): 213 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Hassan, A. Phan, D. Li, C. G. Dagohoy, C. Leary, and J. C. Yao Family History of Cancer and Associated Risk of Developing Neuroendocrine Tumors: A Case-Control Study Cancer Epidemiol. Biomarkers Prev., April 1, 2008; 17(4): 959 - 965. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Garbrecht, M. Anlauf, A. Schmitt, T. Henopp, B. Sipos, A. Raffel, C. F Eisenberger, W. T Knoefel, M. Pavel, C. Fottner, et al. Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity Endocr. Relat. Cancer, March 1, 2008; 15(1): 229 - 241. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Blandamura, A. Parenti, B. Famengo, A. Canesso, P. Moschino, C. Pasquali, S. Pizzi, V. Guzzardo, and V. Ninfo Three cases of pancreatic serous cystadenoma and endocrine tumour J. Clin. Pathol., March 1, 2007; 60(3): 278 - 282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. M. Linehan, P. A. Pinto, R. Srinivasan, M. Merino, P. Choyke, L. Choyke, J. Coleman, J. Toro, G. Glenn, C. Vocke, et al. Identification of the Genes for Kidney Cancer: Opportunity for Disease-Specific Targeted Therapeutics Clin. Cancer Res., January 15, 2007; 13(2): 671s - 679s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. R Woodward and E. R Maher Von Hippel-Lindau disease and endocrine tumour susceptibility. Endocr. Relat. Cancer, June 1, 2006; 13(2): 415 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R Chetty and S L Asa Pancreatic endocrine tumour with cytoplasmic keratin whorls. Is the term "rhabdoid" appropriate? J. Clin. Pathol., October 1, 2004; 57(10): 1106 - 1110. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. B. Marcos, S. K. Libutti, H. R. Alexander, I. A. Lubensky, D. L. Bartlett, M. M. Walther, W. M. Linehan, G. M. Glenn, and P. L. Choyke Neuroendocrine Tumors of the Pancreas in von Hippel-Lindau Disease: Spectrum of Appearances at CT and MR Imaging with Histopathologic Comparison Radiology, December 1, 2002; 225(3): 751 - 758. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. H. Mohr, A. O. Vortmeyer, Z. Zhuang, S. K. Libutti, M. M. Walther, P. L. Choyke, B. Zbar, W. M. Linehan, and I. A. Lubensky Histopathology and Molecular Genetics of Multiple Cysts and Microcystic (Serous) Adenomas of the Pancreas in von Hippel-Lindau Patients Am. J. Pathol., November 1, 2000; 157(5): 1615 - 1621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Shen, Z. Zhuang, D. J. Gersell, and F. A. Tavassoli Allelic Deletion of VHL Gene Detected in Papillary Tumors of the Broad Ligament, Epididymis, and Retroperitoneum in von Hippel-Lindau Disease Patients International Journal of Surgical Pathology, July 1, 2000; 8(3): 207 - 212. [Abstract] [PDF]
|
|
|
|
|
|
S. J. Marx CLINICAL REVIEW 109: Contrasting Paradigms for Hereditary Hyperfunction of Endocrine Cells J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3001 - 3009. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
